Population-wide immune responses to SARS-CoV-2: Insights from quantifying the antibody response
Watch this on-demand webinar to discover a new approach to profiling antibody responses by quantifying affinity and concentration
Watch this on-demand webinar to discover a new approach to profiling antibody responses by quantifying affinity and concentration
The drug candidate was associated with a reduction in the need for supplemental oxygen support, earlier time to discharge from hospital and was well tolerated
Designed to inactivate RNase A in Covid-19 RT-PCR test kits
Learn about the large scale COVID-19 PCR testing program set up by the government of Luxembourg
The multi-analyte respiratory panel combines Flu A/B and respiratory syncytial virus (RSV) targets with the SARS-CoV-2 target
Updated version of highly sensitive and accurate COVID-19 PCR kit accounts for known and future viral mutations
Solutions combine liquid-based sample preparation with PCR detection and Sanger sequencing
Learn more about the efficient and reproducible multiplex immunoassays set to change the way COVID-19 researchers profile antibody response
Explore topics from Alzheimer's disease and mRNA vaccine production to SARS-CoV-2 detection in wastewater and nanoplastic characterization
This cutting-edge technology has the potential to vastly improve care, offering accessible and affordable brain imaging that can take place at the patient’s bedside
Dr. Vikramsingh Gujar, from Northwestern University, discusses his research on inflammatory disorders and why effective knowledge share is vital for scientific advancement
The assay is fueling discovery in preserved tissue samples to advance clinical translational research
The first-of-its-kind steerable delivery system is designed to seal the left atrial appendage in people who are at increased risk of stroke due to atrial fibrillation
Consortium formed to lower costs of cell and gene therapies through process development and manufacturing collaborations
The research also found the presence of detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality
Tested on human blood in the lab, the selective nanocapsules could reduce the side effects of a major blood clot-dissolving drug, which include bleeding on the brain
It is hoped the project will lead to improved quality of life for patients
OncoHost’s AI-Based proteomic profiling platform, PROphet, to serve key role in host response evaluation of late-stage disease patients